Traditional Chinese medicine composition for treating lower extremity atherosclerotic disease and application of composition

Abstract

The invention provides a traditional Chinese medicine composition for treating a lower extremity atherosclerotic disease (LEAD). The traditional Chinese medicine composition comprises 25-40 parts of radix astragali and 10-20 parts of mulberry, also can comprise 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of Chinese angelica, 6-12 parts of earthworm and 5-8 parts of leech, and can further comprise 6-12 parts of rhizoma acori tatarinowii, 6-12 parts of rhizoma alismatis, 5-15 parts of tea tree root and 5-18 parts of radix achyranthis bidentatae in parts by weight. The invention also provides application of the traditional Chinese medicine composition in preparing a medicine for treating the LEAD. The traditional Chinese medicine composition provided by the invention has the advantages that the medicine offers syndrome differentiation and treatment with the characteristics of traditional Chinese medicine according to the symptoms of the LEAD, and has the effects of activating blood, dredging collaterals and resolving phlegm while placing extra emphasis on replenishing qi and tonifying deficiency so as to fundamentally improve the constitution of a patient, cut the links of worsening the phlegm, deficiency and stasis under a mutual effect, reduce the danger of transferring vessel impediment to heart in terms of prevention and control and realize an obvious curative effect; and the composition does not have toxic and side effects, is easily accepted by the patient, is made from few raw materials, is low in cost, and adopts a simple preparation technology.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating atherosclerotic diseases of lower extremities and its application, in particular, it is a Chinese patent medicine prepared from Chinese herbal medicines as raw materials. Background technique [0002] Lower extremity atherosclerotic disease (LEAD) refers to a disease in which lower extremity atherosclerosis leads to arterial stenosis or even occlusion, resulting in chronic or acute ischemic symptoms in lower extremity tissues. According to Chinese literature reports, 16.4% of the elderly population over 60 years old in Beijing, 22.5% of the metabolic syndrome population, and 19.4% of the diabetic population, the incidence rate is very high. [0003] There is no record of "arteriosclerosis of the lower extremities" in the medical books of the motherland. According to the clinical manifestations of LEAD, the disease should belong to the category of "removal of gangrene" and...

AI Technical Summary

Problems solved by technology

The number of medicinal flavors of the above-mentioned two kinds of medicines is more, which brings inconvenience to the preparation of medicines, and also increases the cost of medicines.

Images